Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 2, 2000, Pages 225-230

  Johnson, Alan P ^a   Warner, Marina ^a   Livermore, David M ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0033974515     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.2.225     Document Type: Article

References (10)

1. Johnson, A. P. (1998). Antibiotic resistance among clinically important Gram-positive bacteria in the UK. Journal of Hospital Infection 40, 17-26.
2. Hiramatsu, K. (1998). Vancomycin resistance in staphylococci. Drug Resistance Updates 1, 135-50.
3. Ford, C. W., Hamel, J. C., Stapert, D., Moerman, J. K., Hutchinson, D. K., Barbachyn, M. R. et al. (1997). Oxazolidinones: new antibacterial agents. Trends in Microbiology 5, 196-200.
4. Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
5. British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association Working Party. (1998). Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. Journal of Hospital Infection 39, 253-90.
6. George, R. C., Johnson, A. P., Speller, D. C., Efstratiou, A., Broughton, K. & Patel, B. C. (1997). Serogroups/types and antibiotic resistance of referred isolates of Streptococcus pneumoniae, 1993-1995. Communicable Disease Report CDR Review 7, R159-64.
7. Wise, R., Andrews, J. M., Boswell, F. J. & Ashby, J. P. (1998). The in-vitro activity of linezolid (U-100766) and tentative breakpoints. Journal of Antimicrobial Chemotherapy 42, 721-8.
8. Eliopoulos, G. M., Wennersten, C. B., Gold, H. S. & Moellering, R. C., Jr. (1998). In vitro activities of new oxazolidinone antimicrobial agents against enterococci. Antimicrobial Agents and Chemotherapy 40, 1745-7.
9. Stalker, D. (1998). Linezolid pharmacokinetics. In Abstracts of Symposium on Oxazolidinones: the Second European Congress of Chemotherapy, Hamburg, Germany 1998.
10. Jones, R. N., Johnson, D. M. & Erwin, M. E. (1996). In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrobial Agents and Chemotherapy 40, 720-6.